Diplomat Pharmacy, Inc. : Close to a key point
Entry price | Target | Stop-loss | Potential |
---|
US$29.71 |
US$0 |
US$28.4 |
-100% |
---|
Diplomat Pharmacy is back on its support area and this is a strategic entry point.
From a fundamental viewpoint, Diplomat Pharmacy has undeniable qualities. Growth is likely to be because the Thomson Reuters consensus counts on sales increase for the current year.
The area of the USD 29.65 support should enable the stock to have a new bullish trend. The short term support in this area confirms its relevance. Technically, above these levels, 4-traders analysts are optimistic and count on a return toward the short-term resistances.
Investors can open a long trade in the USD 29.65 area. In the first instance, the target price will be the 20-day moving average at USD 33. In case of breakdown of the USD 29.65 support at closing price, investors should close their trades.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.